Navigation Links
Ajinomoto Althea Inc. Appoints J. David Enloe Jr. as President and Chief Executive Officer
Date:1/6/2014

SAN DIEGO, Jan. 6, 2014 /PRNewswire/ -- Ajinomoto Althea Inc., a leading Contract Manufacturing Organization providing development and manufacturing services for biotechnology and pharmaceutical companies, announced today the appointment of J. David Enloe Jr. as President and CEO. Mr. Enloe will be responsible for developing strategies to support the company's continued growth.

(Logo: http://photos.prnewswire.com/prnh/20131104/LA10040LOGO)

"We are delighted to welcome David as the new leader of Ajinomoto Althea's management team," said Dr. Hiroshi Shiragami, Co-Chair of Ajinomoto Althea Inc. "His unique depth of experience in the biotechnology industry, leadership abilities, financial management, manufacturing and contractual negotiation skills will be instrumental in supporting further expansion of our business."  

Mr. Enloe brings over 20 years of executive management experience most of that in biotechnology, drug development, and GMP manufacturing management.  Most recently, he served as the Head of the Viral Therapeutics Business Unit at Lonza AG, which provides process development, scale-up and GMP manufacturing of viral-based biologics for clients in the US, Europe and Asia.  David was the founder and CEO of Vivante GMP Solutions, Inc., which he subsequently sold to Lonza AG in 2010. Prior to this, he was President and CEO of Introgen Therapeutics, Inc., which later became the basis for Vivante.

"I can't think of a better fit for Ajinomoto Althea.  David's leadership and experience combined with the Ajinomoto Althea team will enhance the company's position as the most trusted outsource manufacturer for those developing tomorrow's successful therapeutics," stated Dr. Magda Marquet, Co-Chair of Ajinomoto Althea Inc.

"I am thrilled to be joining Ajinomoto Althea Inc. at this exciting stage in its history.  Althea has been an outstanding organization for many years now, and with the recent acquisition by Ajinomoto, the company is positioned to expand and grow into an even more significant player in the biologics production and fill/finish markets. The timing of this opportunity for me was perfect and I can't wait to get started," said Mr. Enloe.

Mr. Enloe joined the team effective December 16, 2013.  Dr. Hiroshi Shiragami and Dr. Magda Marquet will continue to serve Ajinomoto Althea Inc. as Co-Chairs of the Board of Directors.

About Ajinomoto Althea  Inc.

Ajinomoto Althea, Inc. is a fully integrated, contract development and manufacturing organization located in San Diego, CA providing clinical and commercial product development services.  Ajinomoto Althea offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA. In conjunction with these manufacturing operations, Ajinomoto Althea offers comprehensive development services including: upstream and downstream process development, analytical development, lyophilization cycle, complex formulation, product release and ICH-compliant stability testing. Ajinomoto Althea's formulation technology platform includes Crystalomics®, a proprietary technology that offers a formulation solution for large molecule products that must be delivered at high concentrations or as sustained release formulations. Ajinomoto Althea also has an innovative and proven recombinant protein expression technology called Corynex®. For more information visit us at WWW.ALTHEATECH.COM.


'/>"/>
SOURCE Ajinomoto Althea Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Shanghai Ajinomoto Amino Acid Co., Ltd. Expands Amino Acid Production Capacity
2. Ajinomoto Althea, Inc. Selected As A Finalist In 26TH Annual CONNECT Most Innovative New Product Awards
3. Ajinomoto Co., Inc. Completes Acquisition of Althea Technologies, Inc.
4. Ajinomoto Co., Inc. Agrees To Acquire Althea Technologies, Inc.
5. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
6. Concord Medical Announces Results of 2013 Annual General Meeting; Appoints New Board Members
7. ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors
8. BioMed Realty Trust Appoints Dr. William R. Brody, President Of The Salk Institute, To Its Board Of Directors
9. Vermillion Appoints Marian E. Sacco as SVP of Sales and Marketing and Chief Commercial Officer
10. Relmada Therapeutics Inc. Appoints Douglas J. Beck As Chief Financial Officer
11. Hologic Appoints Stephen P. MacMillan President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
(Date:6/23/2016)... 2016 Revolutionary technology includes multi-speaker ... , industry leaders in advanced audiology and hearing aid ... Opn ™, the world,s first internet connected hearing aid ... devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) ... of ,world firsts,: , TwinLink™ - the ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... To succeed under value-based payments, healthcare providers ... how to move forward, given the need to sustain current operations. PYA has ... an organization’s specific needs. , PYA Principal Martie Ross states, “Healthcare providers want ...
(Date:6/24/2016)... Brooklyn, New York (PRWEB) , ... June 24, 2016 , ... ... medical marijuana patients optimize the ingestion of their medication by matching users with high ... allows users to compare pieces with no commitment. , Inhale was founded by two ...
(Date:6/24/2016)... ... ... Dr. Seema Daulat, a native Texan and University of Texas at Austin ... July 13, 2016. , Dr. Daulat earned her Doctorate of Medicine (MD) at The ... the Agape Clinic serving Dallas’ underprivileged community. , Following medical school, Dr. Daulat completed ...
(Date:6/23/2016)... Los Angeles, CA (PRWEB) , ... June 23, 2016 , ... ... being conducted that may expose a possible link between head and neck cancer in ... individuals participating in the study were evaluated based on whether they had gum disease, ...
(Date:6/23/2016)... ... ... The Mechille Wilson Agency, a Texas-based insurance company that provides coverage to hundreds ... a charity drive to assist a student to be chosen from the local area. ... be presented to the chosen student to help with the growing costs of tuition, ...
Breaking Medicine News(10 mins):